Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

79.25p
   
  • Change Today:
    -1.80p
  • 52 Week High: 85.05
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 965.23m
  • Volume: 1,887,541
  • Market Cap: £764.94m

Latest Deals

Traded Action Notifier PriceAmountValue
12-May-25 Transfer From Giles Wilson 0.000p 261 £0.00
12-May-25 Buy Giles Wilson 57.45p 261 £149.94
11-Apr-25 Transfer From Giles Wilson 0.000p 297 £0.00
11-Apr-25 Buy Giles Wilson 50.55p 297 £150.13
08-Apr-25 Buy Giles Wilson 46.92p 58 £27.21

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
24-Sep-24 Buy Robyn Perriss 51.55p 89,054 £45,907.34
24-Sep-24 Sell Robyn Perriss 51.50p 89,054 £45,862.81
24-Sep-24 Buy Andrew Harrison 51.53p 58,220 £29,999.54
27-Aug-24 Buy Lynne Weedall 74.41p 25,000 £18,603.62
25-Mar-25 Buy Giles Wilson 54.01p 32,640 £17,628.31

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £6,240,938
Giles Wilson 110,713 £87,740
Robyn Perriss 94,328 £74,755
Andrew Harrison 76,594 £60,701
Lynne Weedall 40,054 £31,743
Ian Rogers 20,270 £16,064
Ije Nwokori 5,405 £4,284

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £293,179,384
IngreGrsy Limited 369,942,440 £293,179,384
Permira Holdings Limited 364,142,440 £288,582,884
Artemis Investment Management LLP 86,997,521 £68,945,535
Fidelity Management & Research 32,500,000 £25,756,250
Intertrust Employee Benefit Trustee Limited 135,000 £106,988

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 79.25p
Change Today -1.80p
% Change -2.22 %
52 Week High 85.05
52 Week Low 47.52
Volume 1,887,541
Shares Issued 965.23m
Market Cap £764.94m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.71% below the market average27.71% below the market average27.71% below the market average27.71% below the market average27.71% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
18.14% below the market average18.14% below the market average18.14% below the market average18.14% below the market average18.14% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
43.41% below the market average43.41% below the market average43.41% below the market average43.41% below the market average43.41% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 11-Jun-2025

Time Volume / Share Price
16:07 46 @ 80.00p
15:43 10 @ 79.50p
15:43 10 @ 79.60p
15:43 68 @ 79.45p
15:12 174 @ 78.80p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page